Extensive literature reviews indicate CYB5D2 exerts tumor-suppressive effects across multiple malignancies, including breast cancer, hepatocellular carcinoma, lung cancer, and clear cell renal cell carcinoma (ccRCC). This evidence concerns the gene CYB5D2 and lung carcinoma.